IDH-Inhibitoren : = IDH inhibitors

BackgroundSomatic mutations in isocitrate dehydrogenase (IDH) 1 and IDH2 have been identified in multiple human cancers, including glioma, chondrosarcoma, cholangiocellular carcinoma, angioimmunoblastic T cell lymphoma, myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).ObjectiveThis r...

Full description

Bibliographic Details
Published in:Der Onkologe, 23(2017), 8, Seite 632-638
Main Author: Krämer, Alwin (Author)
Other Involved Persons: Heuser, Michael
Format: Article
Language:German
Published: 12. April 2017
ISSN:1433-0415
Item Description:Gesehen am 07.11.2018
Physical Description:7
DOI:10.1007/s00761-017-0220-z
Subjects:
AML
MDS
QR Code: Show QR Code